Skip to main content
Premium Trial:

Request an Annual Quote

Michael Monko, Kreatech Biotechnology


People in the News

Serologicals last week named Michael Monko as vice president of sales for its research products segment, the company said.

Monko previously held senior sales positions at Invitrogen. He holds an MBA from Babson College and a BS in biochemistry from the University of New Hampshire.

New Products

Kreatech Biotechnology last week launched its series of PlatinumBright nucleic acid labeling kits that offer its Universal Linkage System labeling molecule bound to a choice of fluorescent dyes, or haptens, and the company's KREApure purification columns, which remove unreacted dye while yielding sample recovery independent of fragment length, Kreatech said.

The company recommended PlatinumBright for fluorescent in situ hybridization applications, filter hybridizations such as northern blots, southern blots, spot blots and dot blot hybridizations, as well as for use with tissue arrays and chIP-on-chip experiments.


In last week's article, entitled "Arrayjet Adding Features to Flagship Printer as Commercialization Continues," Arrayjet's technical director Howard Manning was misidentified as the UK firm's technical advisor. Also, Peter Ghazal is not Arrayjet's chief scientific officer, but its chief scientific advisor.

In addition, the company will begin shipping its Low Volume 12 Sample Connector Block starting September 1, rather than the "Volume 12 Sample Connector Block" named in the piece. The firm uses the block to enable samples to be loaded into the firm's piezo-electric inkjet print head. Finally, the company said the new components do not affect the readiness of its product, and that it is seeking distribution partners in the United States.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.